Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Basics of Compounding with Dilutions and Concentrates

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2017 - Volume 21, Number 1
View All Articles in Issue

Page(s):  39-45

Basics of Compounding with Dilutions and Concentrates Page 1
Basics of Compounding with Dilutions and Concentrates Page 2
Basics of Compounding with Dilutions and Concentrates Page 3
Basics of Compounding with Dilutions and Concentrates Page 4
Basics of Compounding with Dilutions and Concentrates Page 5
Basics of Compounding with Dilutions and Concentrates Page 6
Basics of Compounding with Dilutions and Concentrates Page 7

Download in electronic PDF format for $75

Abstract:  Pharmacists use various sources for obtaining the active pharmaceutical ingredient for compounding medications. In many cases, it is the pure drug (United States Pharmacopeia, National Formulary, or similar grade); in some cases, it can be a commercial dosage form; and, in some cases, it may be a dilution or concentrate. If the drug is not present at full strength, then adjustments may be necessary to obtain the required quantity of drug. Also, in many cases, it is necessary to use a dilution or a concentrate of a drug due to safety and quality reasons. Presented within this article are new sources of active pharmaceutical ingredients that are now available to aid pharmacists in meeting future United States Pharmacopeia <800> standards. It is critical that the pharmacist be aware of the strength of the drug and any other excipients that may be available.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, trituration, dilution, concentrates, stock preparations, liothyronine sodium, T3, levothyroxine sodium, T4, thyroid replacement, thyroid disorders, solid dilutions, stablity, liquid dilutions, aqueous concentrates, oil concentrates, sex hormones, sex steroids, estrogens, estrone, E1, estradiol, E2, estriol, E3, progesterone, P4, androgen, testosterone, menopause, hormone replacement therapy, HRT, hormone ratios, calculation aid

Related Categories: EXCIPIENTS, FORMULATIONS, HRT, SUPPORT, QUALITY CONTROL

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
Jan/Feb 2017
Pg. 39-45

Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Snyder Scott
, Listecki Robert E
Sep/Oct 2012
Pg. 376-380

Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates
Allen Loyd V Jr
Nov/Dec 2010
Pg. 508-510

Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
Nov/Dec 2008
Pg. 546

Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 545

Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 547

Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 548

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Thyroid Potency Calculations
Stack Bob
Jul/Aug 2010
Pg. 306-309

Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement
Milner Martin
Jul/Aug 2005
Pg. 268-273

Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 247

Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 505

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff
, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Sep/Oct 2015
Pg. 414-419

The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
Jan/Feb 2023
Pg. 22-23

Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony
, Fakata Keri, Stuart William
May/Jun 2008
Pg. 200-207

Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit
Lardinois Benjamin
, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Jul/Aug 2019
Pg. 320-323

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Return to Top